Global Sleep Apnea Devices Market to Grow at a CAGR of 7.8% by 2024 – Large Scale Benefits of Medical Devices is Driving Demand for Medical Platforms.

“The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024”
Global Sleep Apnea Devices Market, By Product Type (Diagnostic Devices (Polysomnographs, Pulse Oximeters, Polygraphs, Actygraph), Treatment Devices (PAP, Facial Interfaces, ASV, Airway Clearance Systems, Oxygen Concentrators, Oral Appliances, Accessories), By End-User (Hospitals, Home Healthcare, Sleep Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Global Sleep Apnea Devices Market has accounted for USD 3.9 billion in 2016, is expected to reach USD 7.1 billion by 2024 at a CAGR of 7.8% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024

For a Brief Sample @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-sleep-apnea-devices-market#utm_source=abnewswire&utm_campaign=Shubham

Global Sleep Apnea Market – Drivers:

Some of the major factors driving the market for sleep apnea devices market aretechnological advancement, increasing prevalence of sleep apnea, rising geriatric population, and changing lifestyle, rising acceptance of home healthcare, increasing awareness of health, changing lifestyles, increasing aging population, rising prevalence of sleep disorder , improving diagnosis rates, introduction to new technologies which improves patient comfort, increasing healthcare spending, improving healthcare infrastructure, rising disposable income.

TECHNOLOGICAL ADVANCEMENT

Technological advancements in sleep apnea devices are on the rise. There are several companies developing advanced devices which stimulate the genioglossus muscle to keep pharyngeal airway open during sleep. Continuous positive airway pressure (CPAP) mask is considerably better than the previously developed devices and are responsible for the modest gains in CPAP compliance Start-up companies are developing more devices which are mostly adjustable and automatic.

INCREASING PREVALENCE OF SLEEP APNEA

Sleep apnea increases the risk of diseases such as heart attack, stroke, and diabetes. Sleep apnea is a disorder which halts breathing for a few seconds during sleep, this disorder occur when the tissues in the upper throat collapse during sleep due to various reasons such as blockage of air, insomnia, shift work, and snoring. Obstructive sleep apnea causes several heart problems like congestive heart failure, coronary artery disease, and irregular heartbeat.

RISING GERIATRIC POPULATION

The world population is ageing in almost every country. The proportion of people aged over 65 years is growing faster than any other age group and sleep apnea is a common disorder in old people and they are diagnosed less with OSA. Sleep apnea in the elderly is caused by increased fat deposits in the head and neck, and changes in body structure.

CHANGING LIFESTYLE

Nowadays, lifestyle of people is changing rapidly. People tend to have high intake of alcohol and drugs, smoking, obesity, unhealthy sleep patterns and postures, lack of awareness, and high stress levels can generate negative impact on health, digestion and immunity. Changing lifestyle and work pressure often leads to the improper diet which may further add to stress and tension in life. Because of busy schedule and hectic lives they are unable to live a healthy life style.

Read more about the market insights @ http://databridgemarketresearch.com/reports/global-sleep-apnea-devices-market/#utm_source=abnewswire&utm_campaign=Shubham

Global Sleep Apnea Devices Market – Segmentation:

On the basis of type, sleep apnea device market is categorized into: diagnostic devices and therapeutic devices. In 2017, diagnostic devices segment is expected to dominate the market with 60.3% market share.

Based on product type, the diagnostic sleep apnea device market is segmented into polysomnography devices, respiratory polygraphs, pulse oximeters and actigraph systems. Polysomnograph segment is expected to dominate the market in future along with the highest growing CAGR of 10.3% in the forecast period. On the basis of product type, the therapeutic sleep apnea devices are segmented into positive airway pressure devices (PAP), continuous positive airway pressure devices (CPAP), automatically adjusting positive airway pressure devices (APAP), masks, adaptive servo ventilation, airway clearance system, oxygen concentrators, oral appliances and accessories.

On the basis of end users, the global sleep apnea devices market is further segmented into hospitals, sleep clinics, community healthcare and home healthcare. In 2017, the hospitals segment dominates the global sleep apnea device market.

Based on geography the market is segmented into 5 geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa. The geographical regions are further segmented into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan,China, Singapore, Brazil, India, Russia, South Africa.

The Global Sleep Apnea Devices Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Global Sleep Apnea Devices Market – Company Overview:

Koninklijke Philips N.V. dominated the sleep apnea devices market in 2016, followed by Natus Medical Incorporated, and Nihon Kohden along with others such as CareFusion Corporation, Curative Medical Inc., ResMed, Fisher and Paykel Healthcare Limited., SomnoMed, BMC Medical Co., Ltd., Compumedics Limited, NatusMedical Inc., DeVilbiss Healthcare, Global Medical Holdings, Itamar Medical Ltd., Weinmann Medical Technology, Cleveland Medical Devices Inc., SOMNOmedics GmbH, Deymed Diagnostic, NovaSom, and Medtronic. 

Table OF Contents:

1. INTRODUCTION

       1.1. OVERVIEW OF THE SLEEP APNEA DEVICES MARKET

       1.2. MARKET SEGMENTATION & COVERAGE

                1.2.1. CURRENCY AND PRICING 

                1.2.2. LIMITATION

2. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS

       2.2. ARRIVING AT THE GLOBAL SLEEP APNEA DEVICES MARKET SIZE

                 2.2.1. MARKET CRACKDOWN APPROACH

                 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

                 2.2.3. DATA TRIANGULATION

                 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

                 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

                 2.2.6. PORTER’S FIVE FORCES MATRIX

                 2.2.7. PEST ANALYSIS

        2.3. ASSUMPTIONS

        2.4. GLOBAL SLEEP APNEA DEVICES MARKET: RESEARCH SNAPSHOT

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW

        4.2. SLEEP APNEA DEVICES MARKET: KEY PRIMARY INSIGHTS

        4.3. MARKET OVERVIEW

                 4.3.1. DRIVERS

                 4.3.2. RESTRAINTS

                 4.3.3. OPPURTUNITIES

                 4.3.4. THREATS

        4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

 5. SLEEP APNEA DEVICES MARKET, BY TYPE

       5.1. OVERVIEW

       5.2. SLEEP APNEA THERAPEUTIC DEVICES

       5.3. SLEEP APNEA DIAGNOSTIC DEVICES

6. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT TYPE

      6.1. OVERVIEW

      6.2. POSITIVE AIRWAY PRESSURE DEVICES MARKET (PAP)

                6.2.1. CONTINUOUS AIRWAY PRESSURE DEVICES MARKET (CPAP)

                6.2.2. BI-LEVEL AIRWAY PRESSURE DEVICES MARKET (BIPAP)

                6.2.3. VARIABLE POSITIVE AIRWAY PRESSURE (VPAP)

                6.2.4. AUTOMATICALLY-ADJUSTING POSITIVE AIRWAY PRESSURE (APAP)

       6.3. MASKS

                6.3.1. NON-VENTED MASKS

                6.3.2. NASAL MASKS

                6.3.3. NASAL PILLOWS

                6.3.4. FULL FACE MASKS

                6.3.5. PAEDIATRIC MASKS

                6.3.6. OTHERS

       6.4. ADAPTIVE SERVO-VENTILATION (ASV)

       6.5. AIRWAY CLEARANCE SYSTEMS

       6.6. OXYGEN CONCENTRATORS 

                6.6.1. STATIONARY CONCENTRATORS 

                6.6.2. PORTABLE CONCENTRATORS 

       6.7. ORAL SLEEP APNEA DEVICES

                6.7.1. MANDIBULAR ADVANCEMENT DEVICES (MAD)

                6.7.2. TONGUE RETAINING DEVICE (TRD)

       6.8. ACCESSORIES

7. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT TYPE

       7.1. OVERVIEW

       7.2. PULSE OXIMETERS

                7.2.1. HANDHELD PULSE OXIMETERS

                7.2.2. FINGERTIP PULSE OXIMETERS

                7.2.3. TABLETOP PULSE OXIMETERS

                7.2.4. WRIST-WORN PULSE OXIMETERS

       7.3. POLYSOMNOGRAPH (PSG)

                7.3.1. CLINICAL PSG

                7.3.2. AMBULATORY PSG DEVICES

       7.4. RESPIRATORY POLYGRAPH

       7.5. ACTIGRAPH

8. SLEEP APNEA DEVICES MARKET, BY END USER

       8.1. OVERVIEW

       8.2. HOSPITALS

       8.3. HOME HEALTHCARE

       8.4. SLEEP CLINICS

       8.5. COMMUNITY HEALTHCARE

9. SLEEP APNEA DEVICES MARKET, BY APNEA TYPE

       9.1. OBSTRUCTIVE SLEEP APNEA

              9.1.1. PATIENT VOLUME

              9.1.2. MARKET SIZE

       9.2. CENTRAL SLEEP APNEA

               9.2.1. PATIENT VOLUME

               9.2.2. MARKET SIZE

       9.3. COMPLEX SLEEP APNEA

                9.3.1. PATIENT VOLUME

                9.3.2. MARKET SIZE

 10. SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY

       10.1. COUNTRYWISE SLEEP APNEA DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

                 10.1.1. NORTH AMERICA

                              10.1.1.1. U.S.

                              10.1.1.2. CANADA

                              10.1.1.3. MEXICO

                 10.1.2. EUROPE

                              10.1.2.1. GERMANY

                              10.1.2.2. FRANCE

                              10.1.2.3. U.K.

                              10.1.2.4. ITALY

                              10.1.2.5. SPAIN

                              10.1.2.6. RUSSIA

                              10.1.2.7. TURKEY

                              10.1.2.8. BELGIUM

                              10.1.2.9. NETHERLANDS

                              10.1.2.10. SWITZERLAND

                              10.1.2.11. REST OF EUROPE

                 10.1.3. ASIA-PACIFIC (APAC)

                              10.1.3.1. JAPAN

                              10.1.3.2. CHINA

                              10.1.3.3. SOUTH KOREA

                              10.1.3.4. INDIA

                              10.1.3.5. AUSTRALIA

                              10.1.3.6. SINGAPORE

                              10.1.3.7. THAILAND

                              10.1.3.8. MALAYSIA

                              10.1.3.9. INDONESIA

                              10.1.3.10. PHILIPPINES

                              10.1.3.11. REST OF APAC

                 10.1.4. SOUTH AMERICA

                              10.1.4.1. BRAZIL

                              10.1.4.2. REST OF LATIN AMERICA

                 10.1.5. MIDDLE EAST AND AFRICA

                              10.1.5.1. SAUDI ARABIA

                              10.1.5.2. REST OF MIDDLE EAST AND AFRICA

        10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

 11. SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE

      11.1. GLOBAL SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

      11.2. U.S. SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

      11.3. EUROPE SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

      11.4. APAC SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

      11.5. MERGERS & ACQUISITIONS

      11.6. NEW PRODUCT DEVELOPMENT & APPROVALS

      11.7.  EXPANSIONS

      11.8. REGULATORY CHANGES

      11.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

 12. SLEEP APNEA DEVICES MARKET, COMPANY PROFILES

       12.1. PHILIPS RESPIRONICS

                12.1.1. OVERVIEW

                12.1.2. SWOT ANALYSIS

                12.1.3. PRODUCT PORTFOLIO

                12.1.4. REVENUE ANALYSIS

                12.1.5. ANALYSTS VIEW

      12.2. RESMED

                12.2.1. OVERVIEW

                12.2.2. SWOT ANALYSIS

                12.2.3. PRODUCT PORTFOLIO

                12.2.4. REVENUE ANALYSIS

                12.2.5. ANALYSTS VIEW

        12.3. FISHER AND PAYKEL HEALTHCARE, LTD.

                12.3.1. OVERVIEW

                12.3.2. SWOT ANALYSIS

                12.3.3. PRODUCT PORTFOLIO 

                12.3.4. REVENUE ANALYSIS

                12.3.5. ANALYST VIEW

       12.4. COMPUMEDICS LIMITED

                12.4.1. OVERVIEW

                12.4.2. SWOT ANALYSIS

                12.4.3. PRODUCT PORTFOLIO

                12.4.4. REVENUE ANALYSIS

                12.4.5. ANALYSTS VIEW

       12.5. SOMNOMED

                12.5.1. OVERVIEW

                 12.5.2. SWOT ANALYSIS

                 12.5.3. PRODUCT PORTFOLIO

                 12.5.4. REVENUE ANALYSIS

                 12.5.5. ANALYSTS VIEW

        12.6. CAREFUSION CORPORATION

                 12.6.1. OVERVIEW

                 12.6.2. SWOT ANALYSIS

                 12.6.3. PRODUCT PORTFOLIO

                 12.6.4. REVENUE ANALYSIS

                 12.6.5. NALYSTS VIEW

        12.7. CURATIVE MEDICAL, INC.

                 12.7.1. OVERVIEW

                 12.7.2. SWOT ANALYSIS

                 12.7.3. PRODUCT PORTFOLIO

                 12.7.4. REVENUE ANALYSIS

                 12.7.5. ANALYSTS VIEW

        12.8. BMC MEDICAL, CO. LTD.

                 12.8.1. OVERVIEW

                 12.8.2. SWOT ANALYSIS

                 12.8.3. PRODUCT PORTFOLIO

                 12.8.4. REVENUE ANALYSIS

                 12.8.5. ANALYSTS VIEW

        12.9. NATUS MEDICAL, INC.

                 12.9.1. OVERVIEW

                 12.9.2. SWOT ANALYSIS

                 12.9.3. PRODUCT PORTFOLIO

                 12.9.4. REVENUE ANALYSIS

                 12.9.5. ANALYSTS VIEW

        12.10. DEVILBISS HEALTHCARE

                 12.10.1. OVERVIEW

                 12.10.2. SWOT ANALYSIS

                 12.10.3. PRODUCT PORTFOLIO

                 12.10.4. REVENUE ANALYSIS

                 12.10.5. ANALYSTS VIEW

        12.11. GLOBAL MEDICAL HOLDINGS, LLC

                 12.11.1. OVERVIEW

                 12.11.2. SWOT ANALYSIS

                 12.11.3. PRODUCT PORTFOLIO

                 12.11.4. REVENUE ANALYSIS

                 12.11.5. ANALYSTS VIEW

        12.12. ITAMAR MEDICAL, LTD.

                12.12.1. OVERVIEW

                 12.12.2. SWOT ANALYSIS

                 12.12.3. PRODUCT PORTFOLIO

                 12.12.4. REVENUE ANALYSIS

                 12.12.5. ANALYSTS VIEW

       12.13. WEINMANN MEDICAL DEVICES GMBH & CO. KG

                 12.13.1. OVERVIEW

                 12.13.2. SWOT ANALYSIS

                 12.13.3. PRODUCT PORTFOLIO

                12.13.4. REVENUE ANALYSIS

                 12.13.5. ANALYSTS VIEW

        12.14. SIBELGROUP

                 12.14.1. OVERVIEW

                12.14.2. SWOT ANALYSIS

                 12.14.3. PRODUCT PORTFOLIO

                 12.14.4. REVENUE ANALYSIS

                 12.14.5. ANALYSTS VIEW

       12.15. AMBULATORY MONITORING, INC.

                 12.15.1. OVERVIEW

                 12.15.2. SWOT ANALYSIS

                 12.15.3. PRODUCT PORTFOLIO

                 12.15.4. REVENUE ANALYSIS

                 12.15.5. ANALYSTS VIEW

       12.16. MEDICOM MTD, LTD.

                 12.16.1. OVERVIEW

                 12.16.2. SWOT ANALYSIS

                 12.16.3. PRODUCT PORTFOLIO

                 12.16.4. REVENUE ANALYSIS

                 12.16.5. NALYSTS VIEW

        12.17. CUSTO MED GMBH

                 12.17.1. OVERVIEW

                 12.17.2. SWOT ANALYSIS

                 12.17.3. PRODUCT PORTFOLIO

                 12.17.4. REVENUE ANALYSIS

                 12.17.5. ANALYSTS VIEW

        12.18. HEINEN LOWENSTEIN GMBH & CO. KG

                 12.18.1. OVERVIEW

                 12.18.2. SWOT ANALYSIS

                 12.18.3. PRODUCT PORTFOLIO

                 12.18.4. REVENUE ANALYSIS

                 12.18.5. ANALYSTS VIEW

        12.19. ERGOLINE GMBH

                 12.19.1. OVERVIEW

                 12.19.2. SWOT ANALYSIS

                 12.19.3. PRODUCT PORTFOLIO

                 12.19.4. REVENUE ANALYSIS

                 12.19.5. ANALYSTS VIEW

        12.20. NEUROVIRTUAL

                12.20.1. OVERVIEW

                 12.20.2. SWOT ANALYSIS

                 12.20.3. PRODUCT PORTFOLIO

                 12.20.4. REVENUE ANALYSIS

                 12.20.5. ANALYSTS VIEW

        12.21. BMC MEDICAL CO., LTD.

                 12.21.1. OVERVIEW

                 12.21.2. SWOT ANALYSIS

                 12.21.3. PRODUCT PORTFOLIO

                 12.21.4. REVENUE ANALYSIS

                 12.21.5. ANALYSTS VIEW

        12.22. SOMNOMEDICS GMBH

                 12.22.1. OVERVIEW

                 12.22.2. SWOT ANALYSIS

                 12.22.3. PRODUCT PORTFOLIO

                 12.22.4. REVENUE ANALYSIS

                 12.22.5. ANALYSTS VIEW

        12.23. CONTEC MEDICAL SYSTEMS CO.,LTD.

                 12.23.1. OVERVIEW

                 12.23.2. SWOT ANALYSIS

                 12.23.3. PRODUCT PORTFOLIO

                 12.23.4. REVENUE ANALYSIS

                 12.23.5. ANALYSTS VIEW

        12.24. CLEVELAND MEDICAL DEVICES INC.

                 12.24.1. OVERVIEW

                 12.24.2. SWOT ANALYSIS

                 12.24.3. PRODUCT PORTFOLIO

                 12.24.4. REVENUE ANALYSIS

                 12.24.5. ANALYSTS VIEW

        12.25. SOMNETICS INTERNATIONAL, INC.

                 12.25.1. OVERVIEW

                 12.25.2. SWOT ANALYSIS

                 12.25.3. PRODUCT PORTFOLIO

                 12.25.4. REVENUE ANALYSIS

                12.24.5. ANALYSTS VIEW

 13. APPENDIX

        13.1. RELATED REPORTS

        13.2. CUSTOMIZABLE OPTIONS

        13.3. SOURCE SHEET

        13.4. BIBLIOGRAPHY

 14. ABOUT DATA BRIDGE MARKET RESEARCH

Related Report

Europe Sleep Apnea Devices Market – Industry Trends and Forecast to 2024

Europe Sleep Apnea Devices Market, By Product Type, By End-Users, By Distribution Channel, By Country (Germany, France, United kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/europe-sleep-apnea-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor:investors@databridgemarketresearch.com

Visit Blog http://databridgemarketresearch.com/blog/  

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Vishal Dixit
Email: Sales@databridgemarketresearch.com
Phone: +1-888-387-2818
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-sleep-apnea-devices-market/#utm_source=abnewswire&utm_campaign=Shubham